Retrospective Evaluation of the Analgesic Effects of Molecular Target Agents Against Cancer Pain and Oxaliplatin-Induced Chronic Peripheral Neuropathy. J. Anal. Oncol. 2022;11:40-44. doi:10.30683/1927-7229.2022.11.06